君实生物: 君实生物第四届监事会第七次会议决议公告
Zheng Quan Zhi Xing·2025-05-29 12:08

Group 1 - The core viewpoint of the announcement is that the company’s supervisory board has approved changes to certain fundraising project sub-items and adjustments to their amounts, which are expected to enhance the efficiency of fund utilization and accelerate the progress of research and development projects [1][2] - The supervisory board meeting was held on May 29, 2025, with all three supervisors present, confirming that the meeting procedures complied with relevant laws and regulations [1] - The proposal for changes and adjustments was unanimously approved by the supervisory board, with all votes in favor and none against or abstaining [2] Group 2 - The adjustments to the fundraising projects are deemed to align with the company's development interests and do not harm the interests of shareholders, particularly minority shareholders [1] - The proposal will be submitted for approval at the company’s upcoming shareholders' meeting [2]